Calquence

Oncology

Indications and Usage

Mantle Cell Lymphoma

CALQUENCE is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.

This indication is approved under accelerated approval based on overall response rate [see Clinical Studies (14.1)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

CALQUENCE is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows

HOW IT WORKS

The easy way to access samples

Create Free AccountRequest, track, and manage samples from multiple brands

Connect with a RepHave access to pharma representatives in one place to request your samples

Get your SampleManage your reps and samples in one place

WHO IS PRESCRIBERPOINT

Increasing patient access to medications they need

At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.

200K+Visitors Each Month

100K+Engagements Each Month

1M+Resources Viewed

WHAT HCPS ARE SAYING

FAQs

All you need to know to order samples

Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.